Use of antibiotics in severe acute pancreatitis

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 3, 2010, Pages 317-324

  De Waele, Jan J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute pancreatitis; Infected pancreatic necrosis; Necrotizing pancreatitis; Severe acute pancreatitis; Walled off necrosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; FLUCONAZOLE; IMIPENEM; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ANAEROBIC BACTERIUM; CANDIDIASIS; CLINICAL FEATURE; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTIOUS PANCREATIC NECROSIS; NONHUMAN; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CANDIDA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HUMANS; PANCREATITIS, ACUTE NECROTIZING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 77649326314     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.3     Document Type: Review

References (52)

1. Pandol SJ, Saluja AK, Imrie CW et al. Acute pancreatitis: bench to the bedside. Gastroenterology 132(3), 127-151 (2007).
2. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 361(9367), 1447-1455 (2003).
3. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch. Surg. 128(5), 586-590 (1993).
4. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 22(3), 274-278 (2001).
5. Nathens AB, Curtis JR, Beale RJ et al. Management of the critically ill patient with severe acute pancreatitis. Crit. Care Med. 32(12), 2524-2536 (2004).
6. Ranson JH, Rifkind KM, Roses DF et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol. Obstet. 139(1), 69-81 (1974).
7. Wilson C, Heads A, Shenkin A et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br. J. Surg. 76(2), 177-181 (1989).
8. Mofidi R, Patil PV, Suttie SA et al. Risk assessment in acute pancreatitis. Br. J. Surg. 96(2), 137-150 (2009).
9. Stimac D, Fisic E, Milic S et al. Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J. Clin. Gastroenterol. 40(3), 209-212 (2006).
10. Mofidi R, Suttie SA, Patil PV et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 146(1), 72-81 (2009).
11. Ueda T, Takeyama Y, Yasuda T et al. Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis. J. Gastroenterol. 44(5), 453-459 (2009).
12. Ueda T, Takeyama Y, Yasuda T et al. Simple scoring system for the prediction of the prognosis of severe acute pancreatitis. Surgery 141(1), 51-58 (2007).
13. Harrison DA, D'Amico G, Singer M. The Pancreatitis Outcome Prediction (POP) Score: a new prognostic index for patients with severe acute pancreatitis. Crit. Care Med. 35(7), 1703-1708 (2007).
14. Singh VK, Wu BU, Bollen TL et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am. J. Gastroenterol. 104(4), 966-971 (2009).
15. Mofidi R, Duff MD, Wigmore SJ et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br. J. Surg. 93(6), 738-744 (2006).
16. De Waele J, Vogelaers D, Decruyenaere J et al. Infectious complications of acute pancreatitis. Acta Clin. Belg. 59(2), 90-96 (2004).
17. Bollen TL, van Santvoort HC, Besselink MG et al. The Atlanta Classification of acute pancreatitis revisited. Br. J. Surg. 95(1), 6-21 (2008).
18. Cicalese L, Sahai A, Sileri P et al. Acute pancreatitis and bacterial translocation. Dig. Dis. Sci. 46(5), 1127-1132 (2001).
19. Strobel O, Wachter D, Werner J et al. Effect of a pneumoperitoneum on systemic cytokine levels, bacterial translocation, and organ complications in a rat model of severe acute pancreatitis with infected necrosis. Surg. Endosc. 20(12), 1897-1903 (2006).
20. De Waele JJ, Leppaniemi AK. Intraabdominal hypertension in acute pancreatitis. World J. Surg 33(6), 1128-1133 (2009).
21. Besselink MG, van Santvoort HC, Boermeester MA et al. Timing and impact of infections in acute pancreatitis. Br. J. Surg 96(3), 267-273 (2009).
22. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br. J. Surg 86(8), 1020-1024 (1999).
23. Beger HG, Bittner R, Block S et al. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91(2), 433-438 (1986).
24. Schein M, Marshall J. Source control for surgical infections. World J. Surg. 28(7), 638-645 (2004).
25. Becker V, Huber W, Meining A et al. Infected necrosis in severe pancreatitis - combined nonsurgical multi-drainage with directed transabdominal high-volume lavage in critically ill patients. Pancreatology 9(3), 280-286 (2009).
26. van Santvoort HC, Besselink MG, Horvath KD et al. Videoscopic assisted retroperitoneal debridement in infected necrotizing pancreatitis. HPB (Oxford) 9(2), 156-159 (2007).
27. Besselink MG, van Santvoort HC, Nieuwenhuijs VB et al. Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN38327949]. BMC Surg. 6, 6 (2006).
28. Otto W, Komorzycki K, Krawczyk M. Efficacy of antibiotic penetration into pancreatic necrosis. HPB (Oxford) 8(1), 43-48 (2006).
29. Adam U, Herms S, Werner U et al. The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis. Infection 29(6), 326-331 (2001).
30. Howard TJ, Temple MB. Prophylactic antibiotics alter the bacteriology of infected necrosis in severe acute pancreatitis. J. Am. Coll. Surg. 195(6), 759-767 (2002).
31. De Waele JJ, Vogelaers D, Hoste E et al. Emergence of antibiotic resistance in infected pancreatic necrosis. Arch. Surg. 139(12), 1371-1375 (2004).
32. Isenmann R, Runzi M, Kron M et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 126(4), 997-1004 (2004).
33. Dellinger EP, Tellado JM, Soto NE et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann. Surg. 245(5), 674-683 (2007).
34. Sainio V, Kemppainen E, Puolakkainen P et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 346(8976), 663-667 (1995).
35. Pederzoli P, Bassi C, Vesentini S et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg. Gynecol. Obstet. 176(5), 480-483 (1993).
36. Bassi C, Falconi M, Talamini G et al. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 115(6), 1513-1517 (1998).
37. Rokke O, Harbitz TB, Liljedal J et al. Early treatment of severe pancreatitis with imipenem: a prospective randomized clinical trial. Scand. J. Gastroenterol. 42(6), 771-776 (2007).
38. Xue P, Deng LH, Zhang ZD et al. Effect of antibiotic prophylaxis on acute necrotizing pancreatitis: results of a randomized controlled trial. J. Gastroenterol. Hepatol. 24(5), 736-742 (2009).
39. Toouli J, Brooke-Smith M, Bassi C et al. Guidelines for the management of acute pancreatitis. J. Gastroenterol. Hepatol. 17(Suppl.), S15-S39 (2002).
40. Uhl W, Warshaw A, Imrie C et al. IAP Guidelines for the surgical management of acute pancreatitis. Pancreatology 2(6), 565-573 (2002).
41. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N. Engl. J. Med. 340(18), 1412-1417 (1999).
42. Dervenis C, Johnson CD, Bassi C et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int. J. Pancreatol. 25(3), 195-210 (1999).
43. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am. J. Gastroenterol. 101(10), 2379-2400 (2006).
44. De Waele JJ, Vogelaers D, Blot S et al. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin. Infect. Dis. 37(2), 208-213 (2003).
45. Novotny AR, Emmanuel K, Hueser N et al. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 145(1), 20-26 (2009).
46. Lepouse C, Murat O, Nicolai F et al. Postoperative procalcitonin kinetics: an indicator for therapeutic strategy in peritonitis? Intensive Care Med. 34(Suppl. 1), S123 (2008).
47. Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J. Surg. 22(2), 158-163 (1998).
48. Vege SS, Gardner TB, Chari ST et al. Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis. Am. J. Gastroenterol. 104(8), 2065-2070 (2009).
49. Kochhar R, Ahammed SK, Chakrabarti A et al. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis. J. Gastroenterol. Hepatol. 24(5), 743-747 (2009).
50. Hoerauf A, Hammer S, Muller-Myhsok B et al. Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit. Care Med. 26(12), 2010-2015 (1998).
51. Gloor B, Muller CA, Worni M et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch. Surg. 136(5), 592-596 (2001).
52. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr. Opin. Crit. Care 13(2), 195-199 (2007).